Picture of Agilent Technologies logo

A Agilent Technologies Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m-4.29%
3m+0.29%
6m+8.71%
1yr-19.55%
Volume Change (%)
10d/3m-29.57%
Price vs... (%)
52w High-7.16%
50d MA0%
200d MA+11.72%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)24.41
PEG Ratio (f)3.55
EPS Growth (f)7.38%
Dividend Yield (f)0.71%
Valuation (ttm)IndustryMarket
Price to Book Value6.66
Price to Tang. Book23.2
Price to Free Cashflow25.01
Price to Sales6.12
EV to EBITDA26.71

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital14.02%
Return on Equity20.95%
Operating Margin19.42%

Financial Summary

Year End 31st OctUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue$m5,1635,3396,3196,8486,8336,776.87,213.576.82%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+24.67-18.3+42.62+4.16+19.99+4.62+10.58n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Oct 202431st Oct 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Agilent Technologies EPS forecast chart

Profile Summary

Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Agilent CrossLab segment offers services portfolio, which includes repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting and various other custom services to support the laboratory operations.

Directors

Last Annual
October 31st, 2023
Last Interim
January 31st, 2024
Incorporated
May 4th, 1999
Public Since
November 18th, 1999
No. of Shareholders
17,721
No. of Employees
17,700
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNew York Stock Exchange
Shares in Issue
293,055,284

A Share Price Performance

Latest News for A

Upcoming Events for A

Q2 2024 Agilent Technologies Inc Earnings Release

Q3 2024 Agilent Technologies Inc Earnings Release

Similar to A

Picture of Abbott Laboratories logo

Abbott Laboratories

us flag iconNew York Stock Exchange

Picture of Agiliti logo

Agiliti

us flag iconNew York Stock Exchange

Picture of Alcon AG logo

Alcon AG

us flag iconNew York Stock Exchange

Picture of Artivion logo

Artivion

us flag iconNew York Stock Exchange

Picture of Avanos Medical logo

Avanos Medical

us flag iconNew York Stock Exchange

FAQ